SuperworthHerbalife market cap HLF
Share price times shares outstanding: what the whole company sells for, since 2010.
- Today, Oct 23, 2026
- $1.4B
- Highest close in our data
- $9.8B
- May 2018
Herbalife is worth $1.4B at the close on Oct 23, 2026, at $13.39 a share.
That is up 63% over the last year and down 74% over five years.
Its highest close in our data was $9.8B in May 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.4B | $1.2B | $2.1B | +2% |
| 2025 | $1.4B | $538.2M | $1.5B | +104% |
| 2024 | $675.3M | $653.1M | $1.3B | −55% |
| 2023 | $1.5B | $1.2B | $2B | +4% |
| 2022 | $1.5B | $1.2B | $5.1B | −68% |
| 2021 | $4.6B | $4.2B | $7.3B | −27% |
| 2020 | $6.3B | $4.1B | $7.6B | −10% |
| 2019 | $7B | $5.2B | $9.4B | −22% |
| 2018 | $9.1B | $6.1B | $9.8B | +54% |
| 2017 | $5.9B | $4.7B | $7.3B | +32% |
| 2016 | $4.5B | $4.1B | $6.3B | −10% |
| 2015 | $5B | $2.8B | $5.5B | +41% |
| 2014 | $3.5B | $3.4B | $8.3B | −55% |
| 2013 | $7.9B | $3.7B | $8.1B | +149% |
| 2012 | $3.2B | $2.9B | $8.4B | −47% |
| 2011 | $6B | $3.9B | $7.3B | +48% |
| 2010 | $4.1B | $3.2B | $4.2B | n/a |
Against its peers
Companies in Healthcare nearest Herbalife's size, closest first, today.
| Company | Market cap |
|---|---|
| HLFHerbalife | $1.4B |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.5B |
| PNTGPennant | $1.5B |
| CNMDCONMED | $1.5B |
| EYENational Vision | $1.5B |
| USPHU S Physical Therapy | $1.3B |
| TRUPTrupanion | $1.3B |
| CDRECadre | $1.3B |
| BVSBioventus | $1.3B |
| PAHCPhibro Animal Health | $1.6B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Herbalife
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.